Literature DB >> 7201017

Symptomatic giardiasis in three patients with X-linked agammaglobulinemia.

P R LoGalbo, H A Sampson, R H Buckley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201017     DOI: 10.1016/s0022-3476(82)80188-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 2.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

3.  Secretory immune response to membrane antigens during Giardia lamblia infection in humans.

Authors:  D M Rosales-Borjas; J Díaz-Rivadeneyra; A Doña-Leyva; S A Zambrano-Villa; C Mascaró; A Osuna; L Ortiz-Ortiz
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 4.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  Antibody response to Giardia muris trophozoites in mouse intestine.

Authors:  M F Heyworth
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

Review 6.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12

Review 7.  Extra-intestinal and long term consequences of Giardia duodenalis infections.

Authors:  Marie C M Halliez; André G Buret
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

8.  Transcriptomic analysis of the host response to Giardia duodenalis infection reveals redundant mechanisms for parasite control.

Authors:  Ernest A Tako; Maryam F Hassimi; Erqiu Li; Steven M Singer
Journal:  MBio       Date:  2013-11-05       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.